| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 24 |
| 1 | CYCLOSPORINE | 21 |
| 2 | DUPILUMAB | 18 |
| 3 | BEVACIZUMAB | 16 |
| 4 | LAMOTRIGINE | 15 |
| 5 | OMEPRAZOLE MAGNESIUM | 15 |
| 6 | ADALIMUMAB | 14 |
| 7 | LATANOPROST | 14 |
| 8 | OMEPRAZOLE | 14 |
| 9 | CAPECITABINE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRACAINE HYDROCHLORIDE | 6 | 0.0451 |
| 1 | OMIDENEPAG ISOPROPYL | 2 | 0.0303 |
| 2 | CARTEOLOL HYDROCHLORIDE | 4 | 0.0120 |
| 3 | PROPARACAINE HYDROCHLORIDE | 6 | 0.0112 |
| 4 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 4 | 0.0101 |
| 5 | CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL | 1 | 0.0093 |
| 6 | MINERAL OIL, PETROLATUM | 5 | 0.0075 |
| 7 | MINERAL OIL, WHITE PETROLATUM | 2 | 0.0069 |
| 8 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 2 | 0.0054 |
| 9 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 17 | 0.0017 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Plasma Volume Expander [EPC] | 4 | 0.0013 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Antiseptic [EPC] | 4 | 0.0009 |
| 5 | Semifluorinated Alkane [EPC] | 2 | 0.0009 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 16 | 0.0008 |
| 7 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 9 | 0.0005 |
| 8 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |